Recursion Pharmaceuticals Inc Clas (RXRX)
R&D Expense Growth
1.95%
Quarterly · Period ending:
RXRX R&D Expense Growth
Latest reported1.95%period ending
Latest reported1.95%period ending
RXRX Quarterly R&D Growth (QoQ) (0.00% → 1.95%)
Latest values, visible window
High-resolution chart · PNG
RXRX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 1.9546% | |
| 5.468% | |
| -31.1601% | |
| -5.8879% | |
| -0.7699% | |
| 31.8303% | |
| 31.815% | |
| 0.909% | |
| 9.4257% | |
| -2.7662% | |
| -0.7499% | |
| 27.1467% | |
| 17.9596% | |
| 6.1323% | |
| 7.6991% | |
| 6.2359% | |
| 18.4889% | |
| -32.8232% | |
| 45.2566% | |
| 12.2266% | |
| 22.8753% | |
| 16.4799% | |
| 25.1769% | |
| 24.849% | |
| 3.1304% | |
| 0% |